Discovery of link between genetic defect on chromosome 15 and epilepsy
Researchers at the University of Maryland School of Medicine have identified a common gene variant that appears to influence people’s risk of developing high blood pressure, according to the results of a study being published online Dec. 29, 2008 in the Proceedings of the National Academy of Sciences (PNAS). The STK39 gene is the first
Full Post: Researchers identify common gene variant linked to high blood pressure
Scientists find link between genetic defect on chromosome 15 and epilepsy.
In a research published in the advanced online publication of the scientific magazine Nature Genetics, researchers have identified a genetic defect for common epilepsies on chromosome 15. A subset of the patients with epilepsy lacked a certain part of this chromosome. Further studies on patients from the USA confirmed this finding. The loss of small chromosomal segments, called microdeletions by geneticists, has previously not been connected with common disorders that also include many types of common epilepsies.
Dr. Ingo Helbig, University of Kiel and Department of Neuropediatrics at the University Medical Center Schleswig Holstein, Germany, is first author on this research study: “So far, we didn’t know that microdeletions, loss of entire chromosomal segments including several genes, can also be a cause for common diseases. This finding will help understand why people suffer from common disorders including epilepsies.”
Up to three percent of the population experience epileptic seizures and one percent suffers from epilepsy, which is characterised by recurrent seizures. The researchers hope that understanding how this genetic defect leads to epilepsy will help develop new drugs against seizures. So far, most genes for epilepsy were only found in rare form of epilepsies. However, hereditary factors are long known to play a much larger role, contributing to many common forms of seizure disorders. Hence, the discovery of the 15q13.3 microdeletions in common epilepsies is an important milestone.
44 coauthors contributed to the recent study, which was coordinated by Dr. Thomas Sander from the Cologne Center of Genomic at the University of Cologne, Germany. On a European level, this project included German groups from Berlin, Bonn, Marburg, Ulm as well as groups from Vienna, Copenhagen, Utrecht (NL), Geneva, Troina (Italy), Marseille and Nice. The research study was performed in collaboration with the group of Dr. Evan Eichler at the Department of Genome Sciences and Howard Hughes Medical Institute at the University of Washington, Seattle. Dr. Eichler is one of the pioneers of research on microdeletions in human disease.
Many authors on this research papers are part of the European EPICURE project of the European Union, a large consortium dedicated to the research of epilepsies.
An international team of scientists have identified a genetic risk factor for epilepsy which may lead to a better understanding of what causes the seizures and the development of new treatments for the condition. Epileptic seizures are triggered by the abnormal, synchronised firing of neuron groups, resulting in a disruption to the central nervous
Full Post: Missing DNA the culprit in epilepsy?
Many people who suffer with epilepsy take a drug called Neurontin to control seizures, enabling them to live healthy active lives. Epilepsy is not a psychological disorder. It is a physical abnormality in the brain involving neurons that clash with other neurons. This can cause convulsions and even unconsciousness. During a convulsion (or seizure), the neurons
Full Post: Neurontin for treating epilepsy
A new Mayo Clinic study found that it is generally safe to withdraw anti-seizure medications in children with epilepsy who have achieved seizure-freedom while on the medication. Researchers found that these children were not at high risk of subsequently developing intractable epilepsy. The study will be presented on Sunday, Dec. 7, at the American Epilepsy
Full Post: Study finds it generally safe to withdraw anti-seizure medication in children with epilepsy
Two children have a seizure. One child never has another seizure. Twenty years later, the other child has a series of seizures and is diagnosed with epilepsy. A study being led by researchers at Rensselaer Polytechnic Institute is looking at what could possibly happen in the development of these two children that would lead
Full Post: New understanding of seizure behaviors and epilepsy
A small percentage of males born with cryptorchidism (failure of one or both testicles to descend into the scrotum), the most frequent congenital birth defect in male children, are more likely to have genetic mutations, including for a syndrome that is a common genetic cause of infertility, according to a study in the November 19
Full Post: Link found between cryptorchidism and genetic mutations